CTRE
CareTrust REIT, Inc.
There isn't enough reported data to score CTRE yet.
CTRE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CTRE's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for real estate companies like CTRE.
CTRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 24x | $38.15 | — |
| Forward | 24x | $38.15 | — |
| Cheap | 25x | $41.05 | +7.6% |
| Fair | 33x | $52.87 | +39% |
| Expensive | 50x | $81.27 | +113% |
Historical ranges are pointers, not guarantees.
CTRE's PE is 24x, but its earnings don't support one, so it isn't a reliable read right now.
CTRE Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CTRE, with profitability holding steady. However, they disagree widely on these estimates.
CTRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.60 | -0.6% |
| Q3 2026 | $1.61 | +19% |
| Q2 2026 | $1.61 | +33% |
| Q1 2026 | $1.58 | +70% |
| Q4 2025 | $1.57 | +96% |
| Q3 2025 | $1.35 | +82% |
| Q2 2025 | $1.21 | +98% |
| Q1 2025 | $0.93 | +75% |
| Q4 2024 | $0.80 | +60% |
CTRE's earnings per share have climbed steadily: $1.61 over the past year, up 19% from the year before, and higher year over year for 10 quarters in a row.
CTRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $176.4M | +33% |
| Q2 2026 | $161.3M | +43% |
| Q1 2026 | $142.8M | +48% |
| Q4 2025 | $134.9M | +55% |
| Q3 2025 | $132.4M | +71% |
| Q2 2025 | $112.5M | +63% |
| Q1 2025 | $96.6M | +53% |
| Q4 2024 | $86.9M | +46% |
CTRE's revenue has grown year over year for 17 quarters in a row: $176M last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 52% | -3.6 points |
| Q2 2026 | 55% | -0.5 points |
| Q1 2026 | 57% | -4.9 points |
| Q4 2025 | 54% | +5.8 points |
| Q3 2025 | 56% | +12 points |
| Q2 2025 | 56% | +38 points |
| Q1 2025 | 62% | +16 points |
| Q4 2024 | 49% | +7.2 points |
CTRE's operating margin was 52% last quarter, down 3.6 points from the same quarter a year ago.
CTRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $154.9M | +53% |
| Q2 2026 | $134.7M | +34% |
| Q1 2026 | $90.4M | +27% |
| Q4 2025 | $121M | +61% |
| Q3 2025 | $100.9M | +50% |
| Q2 2025 | $100.8M | +90% |
| Q1 2025 | $71.4M | +46% |
| Q4 2024 | $75.2M | +76% |
CTRE's free cash flow was $501M over the past year, up 44% from the year before. Free cash flow isn't a meaningful measure for real estate companies like CTRE.
CTRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.9% | +6.8M shares |
| 1 year | +14% | +28.8M shares |
| 3 years | +131% | +137M shares |
| 5 years | +150% | +145M shares |
| Available history | +153% | +146M shares |
CTRE has 241M diluted shares, up 14% from a year ago.
CTRE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.5x | Elevated |
| Q2 2026 | 2.7x | Moderate |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 3.8x | Elevated |
| Q4 2024 | 1.1x | Healthy |
CTRE's net debt is about 3.5 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for real estate companies like CTRE.
CTRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.3 | Neutral |
| Stochastic | 36.2 | Neutral |
CTRE's weekly RSI is 49 (neutral) and its Stochastic is 36 (neutral).
CTRE PE vs Real Estate Sector
| Metric | CTRE | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 0.9% below |
| PE % | 7 | 23 | 16 pts below |
CTRE is trading at 24x earnings, in line with the Real Estate sector's median of 24x, though its earnings don't support one.
CTRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.0 | 3.2% above |
| 20 week MA | $39.0 | 2.1% below |
| 50 week MA | $38.7 | 1.5% below |
| 100 week MA | $34.6 | 10% above |
| 200 week MA | $29.0 | 31% above |
CTRE's trend is mixed: it's above three of its five weekly moving averages, and 31% above its 200-week average.
CTRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.5 | $22.3 | +8.9% |
| 2021 | $22.3 | $22.4 | +0.4% |
| 2022 | $22.4 | $18.9 | -16% |
| 2023 | $18.9 | $22.4 | +18% |
| 2024 | $22.4 | $27.1 | +21% |
| 2025 | $27.1 | $36.7 | +36% |
| 2026 YTD | $36.7 | $38.2 | +4% |
CTRE has finished higher in five of the last six years. It's up 4% so far in 2026.